Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Fujisawa discloses antiplatelet agents

Dec. 24, 1996

Agents for urinary incontinence reported by Dainippon

Dec. 23, 1996

LHRH antagonists under study at Takeda

Dec. 23, 1996

Boehringer Ingelheim's modified anti-ICAM-1 antibodies for inflammatory disorders

Dec. 23, 1996

New antiplatelet drugs from Takeda

Dec. 23, 1996

New antithrombotic agents described by Pfizer

Dec. 23, 1996

Schering-Plough claims novel use for Flt3 ligand

Dec. 23, 1996

Takeda claims new treatments for pancreatitis

Dec. 23, 1996

Regeneron claims novel use for neurotrophic factor

Dec. 23, 1996

Mercian discovers other anthracycline antineoplastic agents

Dec. 20, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....